Human Genetics

, Volume 71, Issue 1, pp 45–48

Genetic polymorphism of human factor I (C3b inactivator)

  • S. Nakamura
  • K. Abe
Original Investigations

Summary

Genetic polymorphism of human factor I (C3b inactivator) has been described using polyacrylamide gel isoelectric focusing electrophoresis of neuraminidase-treated EDTA plasma samples followed by electrophoretic blotting technique. In 435 individuals three different common patterns were observed, and these were controlled by two common alleles at a single locus. The results of typing family material confirmed autosomal codominant Mendelian inheritance. Two common alleles were designated FI*B and FI*A, and gene frequencies were estimated to be 0.8931 and 0.1069 for FI*B and FI*A, respectively. The distribution of phenotypes fitted the Hardy-Weinberg equilibrium. Linkage studies failed to show close linkage between factor I and the major histocompatibility complex.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramson N, Alper CA, Lachmann PJ, Rosen FS, Jandl JH (1971) Deficiency of C3 inactivator in man. J Immunol 107:19–27Google Scholar
  2. Allen FH Jr (1974) Linkage of HLA and GBG Vox Sang 27:382–384Google Scholar
  3. Alper CA, Propp RP (1968) Genetic polymorphism of the third component of human complement (C-prime-3). J Clin Invest 47:2181–2192Google Scholar
  4. Alper CA, Abramson N, Johnston RB Jr, Jandl JH, Rosen FS (1970) Increased susceptibility to infection associated with abnormalities of complement-mediated functions and of the third component of complement (C3) N Engl J Med 282:349–354Google Scholar
  5. Alper CA, Boenisch T, Watson L (1972a) Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med 135:68–79Google Scholar
  6. Alper CA, Rosen FS, Lachmann PJ (1972b) Inactivator of the third component of complement as an inhibitor in the properdin pathway. Proc Natl Acad Sci USA 69:2910–2913Google Scholar
  7. Alper CA, Raum D, Karp S, Awdeh ZL, Yunis EJ (1983) Serum complement “supergenes” of the major histocompatibility complex in man (complotypes) Vox Sang 45:62–67Google Scholar
  8. Awdeh ZL, Alper CA (1980) Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 77:3576–3580Google Scholar
  9. Azen EA, Smithies O (1968) Genetic polymorphism of C-prime-3 (beta-1C-globulin) in human serum. Science 162:905–907Google Scholar
  10. Cooper NR (1975) Isolation and analysis of the mechanism of action of an inactivator of C4b in normal human serum. J Exp Med 141:890–903Google Scholar
  11. Fujita T, Gigli I, Nussenzweig V (1978) Human C4-binding protein: II. Role in proteolysis of C4b by C3b-inactivator. J Exp Med 148:1044–1051Google Scholar
  12. Hobart MJ, Joysey V, Lachmann PJ (1978) Inherited structural variation and linkage relationships of C7. J Immunogenet 5:157–163Google Scholar
  13. Lachmann PJ, Müller-Eberhard HJ (1968) The demonstration in human serum of “conglutinogen-activating factor” and its effect on the third component of complement. J Immunol 100:691–698Google Scholar
  14. Martin A, Lachmann PJ, Halbwachs L, Hobart MJ (1976) Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation. Immunochemistry 13:317–324Google Scholar
  15. Nakamura S, Ooue O, Abe K (1984a) Genetic polymorphism of the seventh component of complement in a Japanese population. Hum Genet 66:279–281Google Scholar
  16. Nakamura S, Ooue O, Akiyama K, Abe K (1984b) Genetic polymorphism of complement C6 and haplotype analysis between C6 and C7 in a Japanese population. Hum Genet 68:138–141Google Scholar
  17. Pangburn MK, Schreiber RD, Müller-Eberhard HJ (1977) Human complement C3b inactivator: Isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution. J Exp Med 146:257–270Google Scholar
  18. Raum D, Marcus D, Alper CA (1980) Genetic polymorphism of human plasminogen. Am J Hum Genet 32:681–689Google Scholar
  19. Raum DD, Awdeh ZL, Glass AD, Yunis E, Alper CA (1981) The location of C2, C4, and BF relative to HLA-B and HLA-D. Immunogenetics 12:473–483Google Scholar
  20. Rodriguez de Cordoba S, Rubinstein P (1984) Genetic polymorphism of human factor H (β1H) J Immunol 132:1906–1908Google Scholar
  21. Rodriguez de Cordoba S, Ferreira A, Nussenzweig V, Rubinstein P (1983) Genetic polymorphism of human C4-binding protein. J Immunol 131:1565–1569Google Scholar
  22. Ruddy S, Austen FK (1971) C3b inactivator of man: II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b. J Immunol 107:742–750Google Scholar
  23. The Nomenclature Committee of the IUIS (1981) Nomenclature of the alternative activating pathway of complement. J Immunol 127:1261–1262Google Scholar
  24. Thompson RA, Lachmann PJ (1977) A second case of human C3b inhibitor (KAF) deficiency. Clin Exp Immunol 27:23–29Google Scholar
  25. Whitehouse DB, Putt W (1983) Immunological detection of the sixth complement component (C6) following flat bed polyacrylamide gel isoelectric focusing and electrophoretic transfer to nitrocellulose filters. Ann Hum Genet 47:1–8Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • S. Nakamura
    • 1
  • K. Abe
    • 1
  1. 1.Department of Legal MedicineTokyo Women's Medical CollegeTokyoJapan

Personalised recommendations